Ignite Creation Date:
2024-05-06 @ 12:58 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03892525
Status:
TERMINATED
Last Update Posted:
2021-07-26
First Post:
2019-03-26
Brief Title:
Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
The Lymphoma Academic Research Organisation
Organization Data
Organization:
The Lymphoma Academic Research Organisation
Class:
OTHER
Study ID:
ITSELF
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Lymphoma Academic Research Organisation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |